14 Heart Attack Clinical Trials in New Orleans, LA (2026)

Q: How do I join a clinical trial in New Orleans?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the New Orleans research site will contact you.

Recruiting Heart Attack Studies in New Orleans

NCT05243966Recruiting

Myriad™ Augmented Soft Tissue Reconstruction Registry

This is an observational study designed to evaluate the safety and clinical outcomes of Myriad™ in soft tissue reconstruction procedures. The study will enroll participants who are undergoing a surgic...

New Orleans, LA800 participantsAroa Biosurgery Limited

View Study Details

NCT07491952Recruiting

Continuous Dual Aspiration Technique With Zoom System for Stroke

This study is designed to evaluate the effectiveness, safety and clinical performance of ADAPT 2.0, first-line aspiration neurothrombectomy with Zoom System with Continuous Dual Aspiration Technique (...

New Orleans, LA750 participantsImperative Care, Inc.

View Study Details

NCT05254743Recruiting

A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

The purpose of Part 1 of this study is to compare the efficacy and safety of pirtobruitinib (LOXO-305) to ibrutinib in participants with CLL/SLL; participants may or may not have already had treatment...

New Orleans, LAPHASE3737 participantsLoxo Oncology, Inc.

View Study Details

NCT03911700Recruiting

Prophylactic Reinforcement of Ventral Abdominal Incisions Trial

This trial is being conducted to evaluate the efficacy of Phasix™ Mesh implantation at the time of midline fascial closure compared to primary suture closure in preventing a subsequent incisional hern...

New Orleans, LANA477 participantsC. R. Bard

View Study Details

NCT05429632Recruiting

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

This is a multi-center, randomized, double-blinded, placebo controlled trial....

New Orleans, LAPHASE3366 participantsPriothera SAS

View Study Details

NCT06570798Recruiting

A Phase 2a Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases

The main objective is to assess the safety and tolerability of inebilizumab in adult participants with active and refractory systemic lupus erythematosus (SLE) with nephritis (Subprotocol A) and to as...

New Orleans, LAPHASE2220 participantsAmgen

View Study Details

NCT06232304Recruiting

Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus

This study aims to investigate the feasibility and effectiveness of a cognitive behavioral coping skills program, Treatment and Education Approach for Childhood-onset Lupus (TEACH), for youth with cSL...

New Orleans, LANA175 participantsMichigan State University

View Study Details

NCT06675344Recruiting

The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life

The purpose of this study it to test the efficacy of a wearable device to improve symptom management and maximize qualify of life in systemic Sclerosis (SSc) patients in a randomized trial. Specifical...

New Orleans, LANA160 participantsRobyn T. Domsic, MD, MPH

View Study Details

NCT04588922Recruiting

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies

SLS009 (formerly GFH009) is a potent and highly selective CDK9 inhibitor. In this study the safety, tolerability, and antitumor activity of single agent SLS009 are assessed in two dose escalation grou...

New Orleans, LAPHASE1160 participantsSellas Life Sciences Group

View Study Details

NCT06148285Recruiting

Hyperbaric Oxygen Therapy in Acute Ischemic Stroke Ischemic Stroke Recovery (Pro00061930)

This study will critically examine the feasibility, safety and efficacy of HBOT during inpatient rehabilitation (IPR) after acute ischemic stroke measured by non-disruption of 3 hours of daily therapy...

New Orleans, LANA120 participantsLCMC Health

View Study Details

NCT05835310Recruiting

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

A Study to evaluate the PK, PD, efficacy, and safety of Anifrolumab in children with moderate to severe active SLE...

New Orleans, LAPHASE3100 participantsAstraZeneca

View Study Details

NCT06655155Recruiting

A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis

The main purpose of this study is to evaluate the effect and safety of efgartigimod PH20 SC compared to placebo in adults with systemic sclerosis. The study consists of a screening period, a treatment...

New Orleans, LAPHASE281 participantsargenx

View Study Details

NCT06925542Recruiting

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

This is a single-arm, open-label, multicenter, ascending dose Phase 1 study evaluating the safety and preliminary efficacy of CTX112 in adult subjects with refractory autoimmune diseases, including ac...

New Orleans, LAPHASE180 participantsCRISPR Therapeutics

View Study Details

NCT05892614Recruiting

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

This is a 2-Part study with Part A, a double-blind, randomized, placebo-controlled, PoC study to evaluate the efficacy, safety, and tolerability of efzofitimod in patients with SSc-ILD. The primary ob...

New Orleans, LAPHASE225 participantsaTyr Pharma, Inc.

View Study Details

About Heart Attack Clinical Trials in New Orleans

A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.

There are currently 14 heart attack clinical trials recruiting participants in New Orleans, LA. These studies are seeking a combined 4,251 participants. Research is being sponsored by Aroa Biosurgery Limited, Imperative Care, Inc., Loxo Oncology, Inc. and 11 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Heart Attack Clinical Trials in New Orleans — FAQ

Are there heart attack clinical trials in New Orleans?

Yes, there are 14 heart attack clinical trials currently recruiting in New Orleans, LA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New Orleans?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Orleans research site will contact you about next steps.

Are clinical trials in New Orleans free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Orleans studies also compensate for your time and travel.

What heart attack treatments are being tested?

The 14 active trials in New Orleans are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.

Data updated July 17, 2026 from ClinicalTrials.gov